[EN] A PHARMACEUTICAL COMPOSITION COMPRISING FEXOFENADINE, FAMOTIDINE AND MELATONIN<br/>[FR] COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA FEXOFÉNADINE, DE LA FAMOTIDINE ET DE LA MÉLATONINE
申请人:CELLIX BIO PRIVATE LTD
公开号:WO2022130040A1
公开(公告)日:2022-06-23
The present disclosure provides a pharmaceutical composition comprising Fexofenadine or salt or hydrates or solvates thereof, Famotidine or salt or hydrates or solvates thereof, and Melatonin or salt or hydrates or solvates thereof. The compositions of the present disclosure may find utility in treatment of urticaria, atopic dermatitis, pruritus and the like acute or chronic allergic reactions and/or dermatological diseases/conditions, and sleep disorders. Aspects of the present disclosure also relates to a method of treating inflammation associated with COVID 19, gastrointestinal diseases, urticaria, atopic dermatitis, pruritus and the like acute or chronic allergic reactions and/or dermatological diseases/conditions, and sleep disorders using the advantageous compositions of the present disclosure.
本公开提供了一种药物组合物,包括Fexofenadine或其盐或水合物或溶剂化物、Famotidine或其盐或水合物或溶剂化物、以及Melatonin或其盐或水合物或溶剂化物。本公开的组合物可用于治疗荨麻疹、特应性皮炎、瘙痒等急性或慢性过敏反应和/或皮肤病/状况,以及睡眠障碍。本公开的方面还涉及使用本公开的优越组合物治疗与COVID 19、胃肠疾病、荨麻疹、特应性皮炎、瘙痒等急性或慢性过敏反应和/或皮肤病/状况,以及睡眠障碍相关的炎症的方法。